Placebo preparation for the proper clinical trial of herbal medicine - requirements, verification and quality control

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 5, Issue 2, 2011, Pages 169-174

  Fai, Cheng K ^a   de Qi, Guan ^b   Wei, Ding A ^c   Chung, Leung P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG INSTITUTE OF VOCATIONAL EDUCATION   (Hong Kong)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Chinese medicine; Clinical trial; Evaluation; Placebo; Quality

Indexed keywords

ARTICLE; CHINESE MEDICINE; CLINICAL STUDY; COLOR; DRUG CAPSULE; DRUG LABELING; DRUG MANUFACTURE; DRUG PACKAGING; EVALUATION RESEARCH; EVIDENCE BASED MEDICINE; HERBAL MEDICINE; ODOR; PATENT; PLACEBO EFFECT; PRIORITY JOURNAL; QUALITY CONTROL; TASTE;

EID: 79954513190     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221311795399237     Document Type: Article

References (19)

1. Qureshi AI, Hutson AD, Harbaugh RE, Stieg PE, Hopkins LN, Hodge CJ, et al. Methods and design considerations for randomized clinical trials evaluating surgical or endovascular treatments for cerebrovascular diseases. Neurosurgery 2004; 54:248-67.
2. Altman DG, Schulz K, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134: 663-9.
3. Wischik, C. M., Wischik, D. J., Staff, R.T., Murray, A. D. Systems for clinical trials. WO2009060191 (2009) & US2010280975 (2010).
4. Fava, M., Schoenfeld, D. System and method for reducing the placebo effect in controlled clinical trials. US7840419 (2010) & US7647235 (2010).
5. Margus, B., Cox, D., Hsu, J. Methods and systems for identifying predisposition to the placebo effect. US7335474 (2008).
6. Briegs, K. L., Detoro, D., Keim, A., Saillot, J.-l. Clinical trial management system. US7054823 (2006).
7. Boyce, M.D. System and method for medical research and clinical trial. US20090313045 (2009).
8. Slotman, G. J. Method for analyzing clinical trial results for efficacy of a therapy. US20100185399 (2010).
9. Guan D-Q, Leung P-C, Cheng K-F, Ding W-A. Systematic review of placebos used in TCM clinical trials. J Nanjing TCM Univ 2006; 22(3): 183-5.
10. Institute of Chinese Medicine, The Chinese University of Hong Kong http://www.icm.cuhk.edu.hk/icm/ch/index.htm [Accessed on: December 12, 2007]
11. Sieveking DP, Woo KS, Fung KP, Lundman P, Nakhla S, Celermajer DS. Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. Int J Cardiol 2005; 105: 40-5.
12. The Chinese medicine council of Hong Kong. Technical guidelines - product safety documents, available at: http://www.cmchk.org.hk/pcm/chi/idx_down.htm.2004 [Accessed on: December 12, 2007]
13. Meilgaard M, Carr BT, Civille GV. Sensory Evaluation Techniques. 3rd ed. CRC Press: USA 1999.
14. Stone H, Sidel JL. Sensory Evaluation Practices. 2nd Ed. Academic Press: San Diego 1993.
15. The world medical association, Inc. The declaration of Helsinki (January 2004). www.wma.net. [Accessed on: December 12, 2007]
16. Simon D. The development of clinical trials. In: Machin D, Day S, Green S, Eds. Text book of clinical trials 2nd. John Wiley & Sons Ltd. 2006; 3-11.
17. Wang X-F, Dong D, Liu F, Li J, Zuo L. Primary exploration of placebo preparation for TCM clinical trial. Liaoning J Tradit Chin Med 2003; 30(12): 966-7.
18. Harlan WR Jr. Research on complementary and alternative medicine using randomized controlled trials. J Altern Complement Med 2001; 7 (Suppl 1):S45-52.
19. Wen Z-H, Lai S-L, Liang W-X, Guo X-F, Wang Q. Further improving the quality of clinical trial report of TCM. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24(11):1022-5.